Market Cap 43 Billion
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (about 70% of sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (12% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 18% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
EPS 2.01 P/E Ratio 57.38
Previous Mon, Jul 29, 2019
Latest Thu, Oct 24, 2019 (In 4 days)
Pay Date --
Sep 10, 2019
Jul 10, 2019
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.